BlackRock Investment Management, LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 31 filers reported holding CYTOSORBENTS CORP in Q2 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q4 2016$21,000
-12.5%
3,7760.0%0.00%
Q3 2016$24,000
+41.2%
3,7760.0%0.00%
Q2 2016$17,000
+70.0%
3,776
+45.7%
0.00%
Q1 2016$10,000
-28.6%
2,5910.0%0.00%
Q4 2015$14,000
-6.7%
2,591
+7.4%
0.00%
Q3 2015$15,0000.0%2,4130.0%0.00%
Q2 2015$15,0002,4130.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
CM Management, LLC 450,000$1,6161.58%
Skylands Capital, LLC 2,793,470$10,028,5571.44%
Sargent Investment Group, LLC 1,289,546$4,629,4701.12%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 237,940$854,2050.96%
Avenir Corp 2,719,732$9,763,8380.86%
Granahan Investment Management 1,616,587$5,803,5470.18%
Seelaus Asset Management LLC 20,450$730.06%
Cowen Prime Advisors LLC 42,301$151,8610.05%
HighMark Wealth Management LLC 10,000$35,9000.03%
Key Client Fiduciary Advisors, LLC 12,000$43,0800.02%
View complete list of CYTOSORBENTS CORP shareholders